Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Remifentanil Infusion Alone During the Closure Period for Early Emergence and Hemodynamic Stability in Patients Undergoing Supratentorial Craniotomy

NCT02593942 is registered in ClinicalTrials.gov with Yeditepe University Hospital as lead sponsor.

NCT NCT02593942
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02593942 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Remifentanil Infusion Alone During the Closure Period for Early Emergence and Hemodynamic Stability in Patients Undergoing Supratentorial Craniotomy
Lead sponsor
Yeditepe University Hospital
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2015
Completion date
September 30, 2015
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

supratentorial neoplasms